Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool

BACKGROUND: Since the World Health Organization declared coronavirus disease (COVID-19) as a pandemic, most countries started treating their patients with various therapies. However, the data regarding their safety and effectiveness is still lacking. OBJECTIVES: We aimed to evaluate the adverse drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehail, Bashayer, Al Jamea, Zainab, Chacko, Royes, Alotaibi, Fawaz, Ismail, Nadia, Alshayban, Dhafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800535/
https://www.ncbi.nlm.nih.gov/pubmed/35125905
http://dx.doi.org/10.1016/j.jsps.2022.01.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800535/
https://www.ncbi.nlm.nih.gov/pubmed/35125905
http://dx.doi.org/10.1016/j.jsps.2022.01.021

Ejemplares similares